Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cross-bridge Cycle01:26

Cross-bridge Cycle

118.4K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
118.4K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

738
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
738
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.0K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.0K
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

1.4K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
1.4K
Neural Regulation01:37

Neural Regulation

40.4K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
40.4K
Chemical Synapses01:26

Chemical Synapses

9.3K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
9.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Factors influencing accelerated progression in behavioral variant frontotemporal dementia.

Journal of neurology·2026
Same author

Long-term efficacy following venous stenting for symptomatic iliofemoral venous obstruction: 5 year clinical and stent outcomes in a Southeast Asian population.

Journal of vascular surgery. Venous and lymphatic disorders·2026
Same author

Interscalene nerve block for endovascular treatment of brachiocephalic arteriovenous fistula: A pilot study.

The journal of vascular access·2026
Same author

BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial.

Nature medicine·2026
Same author

Cracking the Calcium Barrier: Intravascular Lithotripsy for Peripheral Arterial Disease-1-year Outcomes From 50 Procedures in a Singapore Tertiary Hospital.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists·2025
Same author

Self-Limited Pseudogigantomastia Following Sternal Cryoablation.

Journal of vascular and interventional radiology : JVIR·2025

Related Experiment Video

Updated: Sep 22, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.8K

Amyotrophic lateral sclerosis mimics.

Justin Kwan1, Mithila Vullaganti2

  • 1National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.

Muscle & Nerve
|May 24, 2022
PubMed
Summary
This summary is machine-generated.

Amyotrophic lateral sclerosis (ALS), a motor neuron disorder, is diagnosed clinically. Recognizing ALS mimics is crucial for accurate diagnosis and timely treatment, as up to 10% of initial ALS diagnoses may be incorrect.

Keywords:
amyotrophic lateral sclerosisdifferential diagnosislower motor neuron diseasemimicmotor neuron diseaseupper motor neuron disease

More Related Videos

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.3K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.2K

Related Experiment Videos

Last Updated: Sep 22, 2025

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis
08:59

Real-Time Fluorescent Measurement of Synaptic Functions in Models of Amyotrophic Lateral Sclerosis

Published on: July 16, 2021

2.8K
Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
08:16

Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis

Published on: March 4, 2014

32.3K
Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS
12:35

Clinical Testing and Spinal Cord Removal in a Mouse Model for Amyotrophic Lateral Sclerosis ALS

Published on: March 17, 2012

28.2K

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Medicine

Background:

  • Amyotrophic lateral sclerosis (ALS) is the most frequent adult-onset motor neuron disease.
  • It involves progressive degeneration of motor neurons in the cortex, bulb, and spinal cord.
  • Accurate diagnosis is essential as ALS mimics can present similarly but may have better prognoses or treatments.

Purpose of the Study:

  • To highlight the importance of differentiating ALS from its mimics.
  • To emphasize the clinical nature of ALS diagnosis and the lack of specific biomarkers.
  • To guide clinicians in identifying atypical features that suggest alternative diagnoses.

Main Methods:

  • Clinical diagnosis of ALS relies on excluding other disorders.
  • Review of clinical presentations of ALS and its mimics.
  • Attention to atypical features in patient history and examination.

Main Results:

  • Up to 10% of patients initially diagnosed with ALS may have a mimic disorder.
  • True ALS mimics are rare but critical to identify.
  • Distinguishing ALS from mimics is paramount for appropriate patient management.

Conclusions:

  • Clinical vigilance is required to differentiate ALS from disorders with similar presentations.
  • Correctly identifying ALS mimics prevents misdiagnosis and allows for targeted therapies.
  • Understanding the spectrum of ALS and its mimics is key in neurological practice.